Shareholder Report Of Cannamed For 2014 2nd Quarter

Our service contracts initiate revenues to CannaMed this quarter. Future Financings: New 506(c) Private Placement up to $10,000,000 We are now beginning a new private offering under Rule 506(c) of Regulation D whereby we intend to raise up to an additional $10,000,000.

We intend to use the net proceeds from this offering to support our core business solutions and strengthen future revenue streams. More specifically, the proceeds will be deployed for working capital, real estate purchases, secured loans and financings, marketing and sales of our Cannabis Compliance Platform and credit card processing services, investor relations and communications, potential sponsorships in R&D opportunities, industry associations, as well as a reserve of contingency capital to address any new and potential opportunities.

We invite all accredited investors to contact us for a full copy of our Business Plan and Private Placement Memorandum. 1 Management’s Discussion of Operations CannaMed, through its wholly-owned subsidiaries 1849 Holdings, Inc. (“1849”) and Cal-Westridge, LLC (“Cal-West”), provides financing and turnkey support solutions to lawfully operating participants in the legal cannabis industry. Cal-West provides financing and capital to collectives, producers, property owners, and other legal cannabis industry participants.

To read more, visit

Posted in: Investing

Comments are closed.